Isabel Carrillo reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Isabel Carrillo
What is Ewing Sarcoma?
MAY 2023
Unveiling the Silent Threat: Recognizing the Symptoms of Lung Cancer
FEBRUARY 2023
Childhood Acute Lymphoblastic Leukemia
JUNE 2022
What is Germ Cell Cancer?
JUNE 2022
Balancing Follicular Lymphoma Treatment with Your Life
JUNE 2022
Things to Know About Relapsed or Refractory Diffuse Large B-Cell Lymphoma
JUNE 2022
Myelofibrosis and Nutrition
APRIL 2022
PIK3CA Gene Mutation Ultimate Guide
MARCH 2022
Myelofibrosis; Treatment, Prevention & Management
MARCH 2022
What Is a Biomarker? How Is It Used in Clinical Trials?
FEBRUARY 2022
Immunotherapy Treatment for Esophageal Cancer
JANUARY 2022
NRG1 Fusion Breast Cancer
SEPTEMBER 2021
Secondary Myelofibrosis
AUGUST 2021
Non Small Cell Lung Cancer Treatment
MAY 2021
Massive Bio Exhibit in ASCO Annual Meeting
MAY 2021
Triple Negative Breast Cancer
APRIL 2021
Use of Ruxolitinib in Myelofibrosis
FEBRUARY 2021
V617f-Positive Myelofibrosis
FEBRUARY 2021
What Causes Bladder Cancer?
JANUARY 2021
Genomic Testing for Prostate Cancer
NOVEMBER 2020
Follicular Lymphoma Stage 4
SEPTEMBER 2020
Clinical Trial Pre-screening with Artificial Intelligence
JUNE 2020
Massive Bio Completes SOC 2 Type 1 Certification
MAY 2020
Lung Cancer Clinical Trials
MAY 2020
No articles match your search.